Skip to main content
Clinical Trials/NCT00676364
NCT00676364
Completed
Phase 4

A Randomized, Placebo-Controlled Trial to Evaluate Pain and Anxiety During Venipuncture in Pediatric Patients With or Without Pre-treatment by a Topical Anesthetic

Jenny Boucher, PharmD1 site in 1 country114 target enrollmentMarch 2003

Overview

Phase
Phase 4
Intervention
4% lidocaine topical anesthetic cream
Conditions
Pain
Sponsor
Jenny Boucher, PharmD
Enrollment
114
Locations
1
Primary Endpoint
Pain From Venipuncture
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the amount of anxiety and pain felt by children during procedures that require a needle stick after using a topical anesthetic or placebo cream.

Detailed Description

Pediatric patients frequently receive eutectic mixture of local anesthetics (EMLA) or other anesthetic medications prior to venipuncture. However, the time for the anesthetic to take affect is approximately 60 minutes. Another anesthetic medication besides EMLA is lidocaine 4% topical anesthetic cream (LMX4), which has a shorter acting time (30 minutes) compared to the EMLA, making it a more desirable medication when urgent labs are required. This medication is being evaluated to assess the anxiety and pain associated with venipuncture in 15 minutes versus the approved 30 minutes of pediatric patients treated as an inpatient or outpatient in the local Emergency Department, compared to standard care (no prior treatment).

Registry
clinicaltrials.gov
Start Date
March 2003
End Date
February 2008
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Jenny Boucher, PharmD
Responsible Party
Sponsor Investigator
Principal Investigator

Jenny Boucher, PharmD

Investigator

Lehigh Valley Hospital

Eligibility Criteria

Inclusion Criteria

  • children ages 5-18 years of age
  • treated as an inpatient or outpatient at Lehigh Valley Hospital within the past 24 hours
  • venipuncture order, and that order is their initial venipuncture order (required within 30 mins)

Exclusion Criteria

  • known allergy to EMLA, LMX4 or any of their ingredients
  • known sensitivities to local anesthetics of the amide type, lidocaine or prilocaine
  • G6PD deficiency
  • methemoglobinemia or concomitant administration of methemoglobin-inducing agent
  • brain injured or disoriented (Glasgow Coma Scale \<15)
  • cognitively impaired (Mini Mental Status Exam \<28)
  • active skin conditions at venipuncture site including frequent rashes, eczema or unexplained bruising

Arms & Interventions

4% lidocaine topical anesthetic cream

This group received topical 4% lidocaine anesthetic cream under occlusive dressing for 15 minutes prior to needle stick.

Intervention: 4% lidocaine topical anesthetic cream

Placebo

This group received matching placebo cream under occlusive dressing for 15 minutes prior to needle stick.

Intervention: Placebo cream

Outcomes

Primary Outcomes

Pain From Venipuncture

Time Frame: Pain was measured immediately after venipuncture.

Pain was measured immediately after venipuncture by the participant using the six-point FACES scale. "FACES" in not an acronym, but rather a description of a pain scale that uses pictures of faces in various states of pain. The FACES pain scale is a common scale used to measure pain with scores on a scale. The scale we used had six points from zero (0) to five (5) indicating different levels of pain. Lower scores indicate lower levels of pain, and higher scores indicate higher levels of pain.

Secondary Outcomes

  • Anxiety of Venipuncture(During venipuncture)

Study Sites (1)

Loading locations...

Similar Trials